Literature DB >> 33379399

Sex Differences in Placental Protein Expression and Efficiency in a Rat Model of Fetal Programming Induced by Maternal Undernutrition.

Sophida Phuthong1,2, Cynthia Guadalupe Reyes-Hernández1,3, Pilar Rodríguez-Rodríguez1, David Ramiro-Cortijo1,4, Marta Gil-Ortega5, Raquel González-Blázquez5, M Carmen González1, Angel Luis López de Pablo1, Silvia M Arribas1.   

Abstract

Fetal undernutrition programs cardiometabolic diseases, with higher susceptibility in males. The mechanisms implicated are not fully understood and may be related to sex differences in placental adaptation. To evaluate this hypothesis, we investigated placental oxidative balance, vascularization, glucocorticoid barrier, and fetal growth in rats exposed to 50% global nutrient restriction from gestation day 11 (MUN, n = 8) and controls (n = 8). At gestation day 20 (G20), we analyzed maternal, placental, and fetal weights; oxidative damage, antioxidants, corticosterone, and PlGF (placental growth factor, spectrophotometry); and VEGF (vascular endothelial growth factor), 11β-HSD2, p22phox, XO, SOD1, SOD2, SOD3, catalase, and UCP2 expression (Western blot). Compared with controls, MUN dams exhibited lower weight and plasma proteins and higher corticosterone and catalase without oxidative damage. Control male fetuses were larger than female fetuses. MUN males had higher plasma corticosterone and were smaller than control males, but had similar weight than MUN females. MUN male placenta showed higher XO and lower 11β-HSD2, VEGF, SOD2, catalase, UCP2, and feto-placental ratio than controls. MUN females had similar feto-placental ratio and plasma corticosterone than controls. Female placenta expressed lower XO, 11β-HSD2, and SOD3; similar VEGF, SOD1, SOD2, and UCP2; and higher catalase than controls, being 11β-HSD2 and VEGF higher compared to MUN males. Male placenta has worse adaptation to undernutrition with lower efficiency, associated with oxidative disbalance and reduced vascularization and glucocorticoid barrier. Glucocorticoids and low nutrients may both contribute to programming in MUN males.

Entities:  

Keywords:  VEGF; corticosterone; maternal undernutrition; oxidative stress; placenta; sex

Year:  2020        PMID: 33379399     DOI: 10.3390/ijms22010237

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  6 in total

1.  Decreased Adiponectin Levels in Early Pregnancy Are Associated with High Risk of Prematurity for African American Women.

Authors:  Yelizavet D Lomakova; Xinhua Chen; T Peter Stein; Robert A Steer
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

Review 2.  Sexually Dimorphic Accumulation of Persistent Organic Pollutants in Fetuses.

Authors:  Richelle D Björvang; Linn Salto Mamsen
Journal:  Front Toxicol       Date:  2022-05-17

3.  Rodent models in placental research. Implications for fetal origins of adult disease.

Authors:  Nicole Aguilera; Francisca Salas-Pérez; Macarena Ortíz; Daniela Álvarez; Bárbara Echiburú; Manuel Maliqueo
Journal:  Anim Reprod       Date:  2022-04-22       Impact factor: 1.807

4.  Influence of Neonatal Sex on Breast Milk Protein and Antioxidant Content in Spanish Women in the First Month of Lactation.

Authors:  David Ramiro-Cortijo; Andrea Gila-Diaz; Gloria Herranz Carrillo; Silvia Cañas; Alicia Gil-Ramírez; Santiago Ruvira; María A Martin-Cabrejas; Silvia M Arribas
Journal:  Antioxidants (Basel)       Date:  2022-07-28

5.  Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance.

Authors:  Jing Long; Yan Huang; Zhengshan Tang; Yali Shan; Dou Feng; Wenqin Wang; Juan Liu; Ying Huang; Hang Gu; Dewei Guo; Ruojin Yao; Xin Ni
Journal:  Antioxidants (Basel)       Date:  2022-07-31

6.  Fetal Cardiac Lipid Sensing Triggers an Early and Sex-related Metabolic Energy Switch in Intrauterine Growth Restriction.

Authors:  Loïze Maréchal; Benoit Sicotte; Véronique Caron; Michèle Brochu; André Tremblay
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.